🔗 Visit the ClinicalTrials.gov page for NCT01870596
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Targeting DNA damage response in cancer therapy. | Cancer Sci | 2014 | 1.16 |
| 2 | Chemotherapeutic compounds targeting the DNA double-strand break repair pathways: the good, the bad, and the promising. | Front Oncol | 2014 | 1.06 |
| 3 | Molecular Pathways: Overcoming Radiation Resistance by Targeting DNA Damage Response Pathways. | Clin Cancer Res | 2015 | 0.90 |
| 4 | Trial Watch: Targeting ATM-CHK2 and ATR-CHK1 pathways for anticancer therapy. | Mol Cell Oncol | 2015 | 0.86 |
| 5 | New strategies in acute myelogenous leukemia: leukemogenesis and personalized medicine. | Clin Cancer Res | 2014 | 0.83 |